Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
iStock Rating
B
Details...
Enter Symbol
Theravance, Inc. (NASDAQ: THRX)
Sector: Medical
Current Price :
$36.24
52 Week Low
$17.61
52 Week High
$36.24
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
98M
Market Cap:
$3.14B
Avg Volume:
1306340
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Opinion and Analysis
Stocks End Flat Amid Data; Barnes & Noble (BKS) Tumbles
May 13, 2013 04:09 PM |
AIG
,
BKS
,
ELN
,
GLW
,
JOSB
,
THRX
Futures Trim Losses After Retail Sales Data; Theravance (THRX) Surges
May 13, 2013 08:55 AM |
AIG
,
DELL
,
ELN
,
GLW
,
THRX
,
VVUS
Glaxo, Theravance Lung Disease Drug Gains FDA Approval
May 10, 2013 01:34 PM |
GSK
,
THRX
More Articles on THRX..
Press Releases
Theravance to Present at Investor Conferences in June 2013
May 23, 2013 04:05 PM |
THRX
Perfect Trade Setups, How to Play THRX, DAL, FSLR and SLB
May 14, 2013 12:00 PM |
DAL
,
FSLR
,
SLB
,
THRX
Free Research Reports on CLWR, DDD, SNE and THRX Issued by the Bedford Report
May 14, 2013 08:15 AM |
CLWR
,
DDD
,
SNE
,
THRX
More Press Releases on THRX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
THRX
Compare to S&P
YTD
43.57 %
31.66 %
4 Weeks
40.41 %
40.56 %
12 Weeks
50.12 %
45.07 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
10.81 %
EPS Growth in Last Year:
26.67 %
Sales Growth in Last Quarter:
305.52 %
Sales Growth in Last Quarter:
8.17 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##